In a groundbreaking decision, President Trump is poised to sign an executive order reclassifying marijuana to Schedule III, easing federal restrictions and paving the way for vital medical research. This move aims to benefit Americans suffering from chronic pain and other conditions.
President Trump is reviewing the federal classification of marijuana, a potential game-changer for its regulation and taxation. Could this lead to legal changes that reflect state laws?
President Trump hints at reclassifying marijuana as a less dangerous drug, potentially shifting its status from Schedule 1 to Schedule 3. This decision could open doors for research and tax benefits for the cannabis industry.
As cannabis potency debates heat up, experts warn that limiting THC could harm medical users. Understanding the science behind cannabis is crucial for effective regulation and consumer safety.